Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Brawn Biotech Ltd.
Swot
Brawn Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Brawn Biotech Ltd. has 23 Strengths, 8 Weaknesses, 0 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(23)
Weakness
(8)
Opportunity
(0)
Threats
(1)
Others
(2)
Positive Breakout Third Resistance ( LTP > R3)
Companies with no Debt
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Turnaround companies- loss to profit QoQ
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Stock gained more than 20% in one month
Negative to Positive growth in Sales and Profit with Strong Price momentum
Stock with Low PE (PE < = 10)
RSI indicating price strength
Top Gainers
High Volume, High Gain
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years
Declining profitability: Falling ROCE
Stocks rising sharply on very low month volumes
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Quarterly Net Profit with falling Profit Margin (YoY)
